{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Viatris, Inc. Hits New 52-Week High of $17.68, Up 67.36%
Viatris, Inc. has achieved a new 52-week high, reflecting a substantial increase in its stock performance over the past year. With a market capitalization of USD 15,347 million, the company showcases a strong dividend yield and a balanced debt-to-equity ratio, emphasizing its competitive position in the pharmaceuticals sector.
Viatris, Inc. Hits New 52-Week High of USD 17.66
Viatris, Inc. has achieved a new 52-week high, reflecting a substantial increase in its stock price over the past year, significantly outpacing the S&P 500. With a market capitalization of USD 15,347 million, the company offers a high dividend yield despite current losses and maintains a balanced debt-to-equity ratio.
Viatris Stock Hits Day Low of $15.14 Amid Price Pressure
Viatris, Inc. faced a significant stock price decline, reaching an intraday low amid a challenging trading session. Despite a strong monthly performance, recent financial metrics indicate concerns about profitability, including a low Return on Capital Employed and a substantial drop in earnings per share over two quarters.
Viatris, Inc. Hits New 52-Week High at USD 16.46
Viatris, Inc. has achieved a new 52-week high, reflecting a substantial increase in its stock performance over the past year. With a market capitalization of approximately USD 18.7 billion, the company operates in a competitive pharmaceutical sector, showcasing a notable dividend yield and a high price-to-earnings ratio.
Viatris, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals
Viatris, Inc. has recently revised its evaluation amid fluctuating market conditions, with its stock priced at $10.35. The company has experienced significant volatility over the past year, with mixed technical indicators and varied performance compared to the S&P 500, reflecting both challenges and opportunities in the pharmaceutical sector.
Viatris Stock Forms Golden Cross, Signaling Potential Bullish Breakout Ahead
Viatris, Inc. has recently experienced a Golden Cross, indicating a potential shift in momentum. The stock rose 1.15% today, contrasting with the S&P 500's decline. However, Viatris's longer-term performance remains challenging, with significant declines over the past year and five years, suggesting caution for investors.
Is Viatris, Inc. technically bullish or bearish?
As of August 25, 2025, Viatris, Inc. is in a mildly bearish trend, indicated by daily moving averages and a bearish monthly MACD, while underperforming the S&P 500 with year-to-date and one-year returns of -20.80% and -17.14%, respectively.
Is Viatris, Inc. overvalued or undervalued?
As of May 9, 2024, Viatris, Inc. is considered overvalued with a P/E ratio of 38, low returns on equity and capital, and significant underperformance compared to the S&P 500, leading to a valuation grade shift from expensive to risky.
Is Viatris, Inc. overvalued or undervalued?
As of May 9, 2024, Viatris, Inc. is considered risky and overvalued with a P/E ratio of 38, low returns on equity and capital, and a negative year-to-date return of -28.92%, significantly underperforming compared to its peers and the S&P 500.
Is Viatris, Inc. technically bullish or bearish?
As of May 27, 2025, Viatris, Inc. shows a mildly bearish trend due to daily moving averages and monthly Bollinger Bands, despite some mildly bullish signals from the weekly MACD and KST, with overall sentiment dampened by weak RSI signals and underperformance against the S&P 500.
What does Viatris, Inc. do?
Viatris, Inc. is a mid-cap company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $3.24 billion and a net profit of -$3.04 billion. Key metrics include a P/E ratio of 38.00, a dividend yield of 123.82%, and a market cap of approximately $10.5 billion.
How big is Viatris, Inc.?
As of Jun 18, Viatris, Inc. has a market capitalization of $10.50 billion, with recent net sales of $14.26 billion and a net profit of -$3.79 billion.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
